Actuate Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Actuate Therapeutics (ACTU) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Actuate Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Actuate Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Actuate Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $12k | 7.6k | 1.58 |
| 2026-03-31 | $8.8k | 3.9k | 2.29 |
| 2025-09-30 | $17k | 2.5k | 6.69 |
| 2024-12-31 | $24 | 3 | 8.00 |